Dr. Paul Sufka psufka
6 years 10 months ago
Looks like the latest ACR on Air podcast is up — episode 5 — recorded during #ACR19 with host @hausmannMD and @DrBhana and myself as guests. We discuss a couple of our favorite abstracts from the meeting. @ACRheum https://t.co/WHNiHuhenZ
Dr. John Cush RheumNow
6 years 10 months ago
Very cool minilecture on how to read RCTs! https://t.co/jQUawxcEr1
Rheumatology Network RheumatologyNet
6 years 10 months ago
Gout Attacks Intensify with Heart Failure #cardiovascular https://t.co/LxCw8sCv5P https://t.co/ZukMrWuaeF
Jeff Sparks jeffsparks
6 years 10 months ago
Our new review article is online detailing airway inflammation and RA pathogens is - Obstructive lung diseases and risk of rheumatoid arthritis https://t.co/Nmj9Uf6isl https://t.co/ByWVI0fYwa
Dr. John Cush RheumNow
6 years 10 months ago
Guselkumab, anti-IL23 in PsA
Ph3 DISCOVER-1 trial in bio-naive or 30% prior TNFi = Effective at Wk 24
Safety same as with psoriasis trials. No Tb signal, No IBD signal.
#ACR19 Abst0807 @_connectedcare https://t.co/d7hrn8VQO8
I had the pleasure of attending the CSRO legislative update while at #ACR19 and wanted to shed some light on one hot topic, the E/M coding from CMS and the 2021 update.
Dr. John Cush RheumNow
6 years 10 months ago
Phase 2b Bimekizumab study results in PsA shows neutralizing IL 17F and IL 17A may be a new target for LDA/treatment. https://t.co/45Vahy36g7 #ACR19 @uptoTate
abs#2881
Dr. John Cush RheumNow
6 years 10 months ago
I didn’t realize how fast Pegloticase works. Assuming the urate burden of a gout patient, Pegloticase can degrade all the urate in the body over 5-40 days!
#ACR19 3S050 Lipsky @_connectedcare
Eric Ruderman JointMD
6 years 10 months ago
Panel Presentation: What’s New in Psoriatic Arthritis. So honored to join my colleagues Alexis Ogdie, Jose Scher, and Jessie Walsh to discuss the latest therapies in PsA https://t.co/Hl5r5xVygK via @YouTube #Rheumnow #ACR2019 #ACR19 #PsA
Dr. John Cush RheumNow
6 years 10 months ago
Crossreactivity events between allopurinol rashes and febuxostat are very low https://t.co/jVVQhtB0CK
Dr. John Cush RheumNow
6 years 10 months ago
New package labeling says febuxostat should only be considered after allopurinol has been tried or is contraindicated. https://t.co/Sk2MhEiOhv
Dr. John Cush RheumNow
6 years 10 months ago
PANLAR KOL recommendations for MSUS in gout clinic. Abs #301 https://t.co/uziDzNM0VX #ACR19 @uptoTate
@RheumNow
Recent studies have quantified the gender gap among speakers at academic conferences. The largest study of 181 medical conferences held in North America over one decade found an increase in the proportion of female speakers from 25 to 34% over time, and that the underrepresentation of women was more marked at surgical compared to medical conferences.
Our experts say you should: Plan the night before, use the ACR meeting App, work in groups, be involved in social media and, have fun! What's your advice on how to best attend the ACR meeting?
John M. Davis, III JohnDavisIII
6 years 10 months ago
Great piece by @jeffsparks and team on the role of airway inflammation and the pathogenesis of RA. #rheumatoidarthritis #rheum https://t.co/E2euIPuRab
